Skip to search formSkip to main contentSkip to account menu

VACOP-B protocol

National Institutes of Health

Related topics

Related topics

9 relations

Broader (8)

Antineoplastic Combined Chemotherapy ProtocolsBleomycinCyclophosphamideDoxorubicin

Narrower (1)

P-VABEC

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
A prospective, non-randomised phase 1-2 trial of VACOP-B with filgrastim support for HIV-related non-Hodgkin's lymphoma.
2004
2004
A third generation regimen VACOP-B with or without adjuvant radiotherapy for aggressive localized non-Hodgkin's lymphoma: report from the Italian Non-Hodgkin's Lymphoma Co-operative Study Group.
The objective of this multicenter prospective study was to determine the clinical efficacy and toxicity of a polychemotherapeutic… 
2000
2000
VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's…
BACKGROUND AND OBJECTIVE Sequential treatment with the addition of high-dose therapy (HDT) and peripheral blood progenitor cell… 
2000
2000
Transplantation potential of peripheral whole blood primed by VACOP-B chemotherapy plus filgrastim (r-metHuG-CSF) in patients with aggressive non-Hodgkin's lumphoma.
Large volumes of peripheral blood need to be processed to obtain sufficient stem cells for hematopoietic rescue after… 
Review
1999
Review
1999
A prospective study of risk‐adapted therapy for large cell non‐Hodgkin's lymphoma with VACOP‐B followed by high‐dose CBV and autologous progenitor cell transplantation for high‐risk patients in…
Several centres reported a favourable outcome after high‐dose chemotherapy with autologous progenitor cell transplantation in… 
Review
1998
Review
1998
The MACOP-B and VACOP-B combination chemotherapy for young patients with intermediate-grade non-Hodgkin's lymphoma.
1998
1998
Prevention of hepatitis development by interferon-alpha in HBV carriers treated with intensive chemotherapy: a pilot study.
Hepatitis B during or after cancer chemotherapy is one of the most serious complication in hepatitis B virus (HBV) carriers [1-5… 
1998
1998
High incidence of chemotherapy-induced acral erythema in female patients with non-Hodgkin's lymphoma treated with the VACOP-B regimen.
Seven patients, all females out of 29 with non-Hodgkin's lymphoma (NHL) (16 males and 13 females) treated with the VACOP-B… 
1994
1994
Lymphoma-associated pancreatitis as a presenting manifestation of immunoblastic lymphoma.
A 55 year old man presented with clinical signs and symptoms of subacute pancreatitis of unknown aetiology. Two weeks later… 
1993
1993
Prevention of chemotherapy-induced neutropenia using G-CSF with VACOP-B--a case report.
Hematopoietic growth factors, including granulocyte colony-stimulating factor (G-CSF), are being increasingly used to prevent… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)